Literature DB >> 25712241

Increased circulating follicular helper T cells and activated B cells correlate with disease severity in patients with psoriasis.

J Niu1, Z Song1, X Yang1, Z Zhai1, H Zhong1, F Hao1.   

Abstract

BACKGROUND: Follicular Helper T (TFH) Cells are a population of recently discovered CD4(+) T cells involved in autoimmune diseases. However, the contribution of TFH cells in patients with psoriasis remains unknown.
OBJECTIVE: We aimed to investigate the levels of TFH cells, B cells and their clinical relevance in patients with psoriasis.
METHODS: Using multi-colour flow cytometry, we detected different subsets of TFH cells and B cells in the peripheral blood of 27 patients with psoriasis and 13 healthy donors. Serum IL-21 levels were measured by ELISA. The relationship between the levels of TFH cells, IL-21, B cells and disease severity were analysed.
RESULTS: Compared with healthy donors, higher levels of circulating CD3(+) CD4(+) CXCR5(+) cells, CD3(+) CD4(+) CXCR5(+) ICOS(+), CD3(+) CD4(+) CXCR5(+) PD-1(+), CD3(+) CD4(+) CXCR5(+) ICOS(+) PD-1(+) TFH cells and CD19(+) IgD(+) CD27(-) naive B, CD19(+) CD86(+) activated B, but lower levels of CD19(+) IgD(+) CD27(+) preswitch and CD19(+) IgD(-) CD27(+) postswitch memory B cells, were observed in patients with psoriasis. In addition, serum IL-21 levels in patients with psoriasis were significantly higher than those in healthy donors, and showed to be positively correlated with the levels of different subsets of TFH cells, and the level of CD19(+) CD86(+) B cells was also correlated with TFH cells and IL-21 levels. Furthermore, a significant correlation was found between the levels of CD3(+) CD4(+) CXCR5(+) ICOS(+) TFH cells, CD3(+) CD4(+) CXCR5(+) ICOS(+) PD-1(+) TFH cells, CD19(+) CD86(+) B cells and IL-21 with Psoriasis Area and Severity Index scores.
CONCLUSION: The levels of TFH cells and activated B cells were increased in the peripheral blood of patients with psoriasis, and positively correlated with disease severity. These results suggest that TFH cells and activated B cells may play a role in the pathogenesis of psoriasis.
© 2015 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25712241     DOI: 10.1111/jdv.13027

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  12 in total

1.  Myeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell-Suppressor Mechanisms.

Authors:  Lauren Y Cao; Jin-Sung Chung; Takahiro Teshima; Lawrence Feigenbaum; Ponciano D Cruz; Heidi T Jacobe; Benjamin F Chong; Kiyoshi Ariizumi
Journal:  J Invest Dermatol       Date:  2016-05-25       Impact factor: 8.551

2.  Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.

Authors:  Jiao Wang; Liu Liu; Xiao-Ying Sun; Shuo Zhang; Ya-Qiong Zhou; Kan Ze; Si-Ting Chen; Yi Lu; Xiao-Ce Cai; Jia-Le Chen; Ying Luo; Yi Ru; Bin Li; Xin Li
Journal:  Front Pharmacol       Date:  2022-05-05       Impact factor: 5.988

3.  Dissection of a circulating CD3+ CD20+ T cell subpopulation in patients with psoriasis.

Authors:  J Niu; Z Zhai; F Hao; Y Zhang; Z Song; H Zhong
Journal:  Clin Exp Immunol       Date:  2018-03-06       Impact factor: 4.330

4.  Interleukin-21 is associated with the severity of psoriasis vulgaris through promoting CD4+ T cells to differentiate into Th17 cells.

Authors:  Ying Wang; Li-Li Wang; Hao-Yu Yang; Fei-Fei Wang; Xue-Xiu Zhang; Yan-Ping Bai
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

5.  Activated Circulating T Follicular Helper Cells Are Associated with Disease Severity in Patients with Psoriasis.

Authors:  Ying Wang; Lili Wang; Haoyu Yang; Weichang Yuan; Jingyi Ren; Yanping Bai
Journal:  J Immunol Res       Date:  2016-09-28       Impact factor: 4.818

6.  TSLP-activated dendritic cells induce human T follicular helper cell differentiation through OX40-ligand.

Authors:  Lucia Pattarini; Coline Trichot; Sofia Bogiatzi; Maximilien Grandclaudon; Stephan Meller; Zela Keuylian; Melanie Durand; Elisabetta Volpe; Stefania Madonna; Andrea Cavani; Andrea Chiricozzi; Marco Romanelli; Toshiyuki Hori; Alain Hovnanian; Bernhard Homey; Vassili Soumelis
Journal:  J Exp Med       Date:  2017-04-20       Impact factor: 14.307

Review 7.  T Follicular Helper Cells in Autoimmune Disorders.

Authors:  Noémie Gensous; Manon Charrier; Dorothée Duluc; Cécile Contin-Bordes; Marie-Elise Truchetet; Estibaliz Lazaro; Pierre Duffau; Patrick Blanco; Christophe Richez
Journal:  Front Immunol       Date:  2018-07-17       Impact factor: 7.561

8.  Suppressed Programmed Death 1 Expression on CD4+ and CD8+ T Cells in Psoriatic Patients.

Authors:  Joanna Bartosińska; Ewelina Zakrzewska; Dorota Raczkiewicz; Joanna Purkot; Anna Michalak-Stoma; Małgorzata Kowal; Dorota Krasowska; Grażyna Chodorowska; Krzysztof Giannopoulos
Journal:  Mediators Inflamm       Date:  2017-10-17       Impact factor: 4.711

9.  Distribution of Peripheral Memory T Follicular Helper Cells in Patients with Schistosomiasis Japonica.

Authors:  Xiaojun Chen; Wei Li; Yang Zhang; Xian Song; Lei Xu; Zhipeng Xu; Sha Zhou; Jifeng Zhu; Xin Jin; Feng Liu; Gengxin Chen; Chuan Su
Journal:  PLoS Negl Trop Dis       Date:  2015-08-18

10.  Ustekinumab Inhibits T Follicular Helper Cell Differentiation in Patients With Crohn's Disease.

Authors:  Anna-Maria Globig; Nikola Patricia Sommer; Katharina Wild; Josefine Schardey; Katharina Zoldan; Anne Kerstin Thomann; Lucas-Alexander Schulte; Rupert Schreiner; Wolfgang Reindl; Jochen Klaus; Christoph Mathis Schempp; Maike Hofmann; Robert Thimme; Tobias Boettler; Peter Hasselblatt
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.